Tao Synergies Inc. Common Stock(TAOX)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- Industry (SIC)
- FINANCE SERVICES (6199)
- Exchange
- XNAS
- Market Cap
- $0.0B
TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +10.91% | 1 |
| Feb | -8.00% | 1 |
| Mar | +52.14% | 1 |
| Apr | -10.78% | 1 |
| May | -18.45% | 1 |
| Jun | -10.34% | 1 |
| Jul | -11.57% | 2 |
| Aug | -0.69% | 2 |
| Sep | +9.84% | 2 |
| Oct | +17.39% | 1 |
| Nov | +4.26% | 1 |
| Dec | -38.87% | 1 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report: TAOX
Executive Summary:
BULLISH (Confidence Level: 7/10)
Key drivers: Bullish momentum signals from MACD, technical trends aligning with recent price action.
Primary risks: High volatility, beta above market average, potential for sudden price movements.
Investment thesis: TAOX is likely to continue its upward trend in the short-term (1-4 weeks), driven by bullish momentum and positive technical signals. However, high volatility and beta above market average pose significant risks.
Recent news sentiment impact: No recent news available, which reduces the impact of external factors on the stock's price movement.
Technical Analysis:
Trend Direction: Short-term: Uptrend (1-4 weeks), Medium-term: Neutral (1-3 months), Long-term: Downtrend (3-12 months)
Support/Resistance Levels: Key levels to monitor include SMA 20 ($3.81) and the upper Bollinger Band ($4.33).
Momentum Signals:
- RSI interpretation: Neutral (52.78)
- MACD signal: Bullish (crossover above signal line)
- Bollinger Bands position: Squeeze, indicating potential breakout
Volume Analysis: Volume trends are mixed, with a slight increase in volume over the past few days.
News & Sentiment Analysis:
Recent Headlines Summary: No recent news available.
Sentiment Assessment: Neutral due to lack of recent news.
Catalyst Identification: No immediate catalysts identified.
Market Narrative: The stock's price movement is primarily driven by technical signals, with no significant external factors influencing its behavior at this time.
Risk & Volatility Assessment:
Beta Interpretation: High risk (beta above market average).
Volatility Regime: High volatility, with a True Range of $0.25 and an ATR of $0.33.
Options Market Signals: No options data available to analyze.
Downside Protection: Support levels include SMA 20 ($3.81) and the lower Bollinger Band ($3.30).
Market Context & Positioning:
Sector Performance: TAOX is trading within its sector's average volatility range.
Institutional Activity: No clear institutional activity patterns identified.
Correlation Analysis: Correlation with the market (SPY) is moderate, at 0.43.
Relative Valuation: The stock is positioned in a trading range, with no clear relative valuation signal.
Key Levels & Action Items:
Critical Price Levels: SMA 20 ($3.81) and the upper Bollinger Band ($4.33).
Breakout/Breakdown Levels: A breakout above $4.33 or a breakdown below $3.30 could trigger significant price movements.
Time-Sensitive Catalysts: No immediate catalysts identified, but earnings data may become available in the near future.
Risk Management: Consider setting stop-loss levels around SMA 20 ($3.81) and adjusting position sizing according to market conditions.
Please note that this report is based on the provided data and should not be used as a basis for making investment decisions without further analysis and consideration of additional factors.
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
- Beta (1Y vs SPY)
- 3.75
- Correlation (SPY)
- 43.0%
- R²
- 0.19
- Ann. Volatility
- 113.1%
- SPY Volatility
- 13.0%
High volatility - stock moves more than market
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-05-19 | Robert Ephron | Director | Grant (A) | +10,000 opt | — | EDGAR | |
| 2026-05-19 | William S. Singer | Director | Grant (A) | +35,000 opt | — | EDGAR | |
| 2026-05-19 | Joshua Silverman | Executive Chairman | Grant (A) | +200,000 opt | — | EDGAR | |
| 2026-05-19 | ROBERT WEINSTEIN | Chief Financial Officer | Grant (A) | +30,000 opt | — | EDGAR | |
| 2026-05-19 | Bruce Bernstein | Director | Grant (A) | +55,000 opt | — | EDGAR | |
| 2026-04-08 | Robert Ephron | Director | Grant (A) | +800 opt | — | EDGAR | |
| 2026-04-08 | William S. Singer | Director | Grant (A) | +800 opt | — | EDGAR | |
| 2026-04-08 | Bruce Bernstein | Director | Grant (A) | +800 opt | — | EDGAR | |
| 2025-10-17 | Robert Ephron | Director | Mixed | +4,500 | $7.23 | -$21.7K | EDGAR |
| 2025-10-17 | Joshua Silverman | Executive Chairman | Mixed | +60,000 | $7.23 | -$289.2K | EDGAR |
| 2025-10-17 | JONATHAN SCHECHTER | Director | Grant (A) | +10,000 opt | — | EDGAR | |
| 2025-10-17 | William S. Singer | Director | Mixed | +9,000 | $7.23 | -$43.4K | EDGAR |
| 2025-10-17 | Bruce Bernstein | Director | Mixed | +15,000 | $7.23 | -$72.3K | EDGAR |
| 2025-10-17 | ROBERT WEINSTEIN | Chief Financial Officer | Mixed | +6,000 | $7.23 | -$28.9K | EDGAR |
| 2025-07-02 | ALAN J TUCHMAN | Chief Medical Officer | Mixed | +2,589 | $7.85 | -$13.5K | EDGAR |
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Joshua Silverman | Executive Chairman | 126,681 | $561.2K | $0 | 3 | 2026-05-19 |
| 2 | Bruce Bernstein | Director | 30,897 | $136.9K | $0 | 4 | 2026-05-19 |
| 3 | William S. Singer | Director | 19,566 | $86.7K | $0 | 4 | 2026-05-19 |
| 4 | ROBERT WEINSTEIN | Chief Financial Officer | 16,574 | $73.4K | $0 | 3 | 2026-05-19 |
| 5 | JONATHAN SCHECHTER | Director | 14,035 | $62.2K | $0 | 2 | 2025-10-17 |
| 6 | Robert Ephron | Director | 7,500 | $33.2K | $0 | 3 | 2026-05-19 |
| 7 | ALAN J TUCHMAN | Chief Medical Officer | 3,909 | $17.3K | $0 | 1 | 2025-07-02 |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.